Total Return chart Lundbeck Nasdaq Copenhagen

Stocks

Market Closed - Nasdaq Copenhagen 01:20:00 19/09/26 am AEST			5-day change	1st Jan Change
40.50 ^DKK	+2.66%		-7.53%	+11.88%

11/09	Lundbeck's Asedebart Gets US FDA Orphan Drug Designation for Endogenous Cushing's Syndrome	MT
11/09	Lundbeck wins US orphan drug status for asedebart in Cushing's syndrome	FW

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.